Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 10.26
-0.20 (-1.91%)
Jul 30, 2026, 10:55 AM CST
SHE:301211 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 33.8 | 34.91 | 91.55 | 176.12 | 125.79 | 121.65 |
Depreciation & Amortization | 43.37 | 43.37 | 25.43 | 21.66 | 21.76 | 19.37 |
Other Amortization | 0.29 | 0.29 | 0.29 | 0.1 | - | - |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | - | -0.18 | -0.04 | 0.07 |
Asset Writedown & Restructuring Costs | 0.02 | 0.02 | 0.11 | 2.58 | 0.66 | 0 |
Loss (Gain) From Sale of Investments | -29.14 | -29.14 | -19.03 | -4.02 | - | -10.7 |
Provision & Write-off of Bad Debts | 0.23 | 0.23 | 0.07 | -0.6 | -1.72 | 1.02 |
Other Operating Activities | -1.74 | 5.67 | -1.76 | -3.5 | -4.59 | 4.42 |
Change in Accounts Receivable | -14.14 | -14.14 | 1.27 | 49.31 | 31.65 | -61.53 |
Change in Inventory | 10.83 | 10.83 | 35.95 | -59.1 | -25.21 | 45.09 |
Change in Accounts Payable | -45.26 | -45.26 | -39.44 | -46.29 | 100.9 | 3.92 |
Operating Cash Flow | -0.97 | 7.55 | 96.07 | 137.06 | 250.79 | 123.98 |
Operating Cash Flow Growth | - | -92.14% | -29.91% | -45.35% | 102.28% | 1.90% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -44.75 | -52.33 | -164.43 | -186.53 | -75.95 | -21.07 |
Sale of Property, Plant & Equipment | 0.03 | 0.03 | 0.09 | 0.47 | 0.06 | 0.01 |
Investment in Securities | 29.25 | -0.75 | -949.58 | -21.4 | -103.98 | 240 |
Other Investing Activities | 13.62 | 15.76 | 4.45 | - | - | 10.7 |
Investing Cash Flow | -1.86 | -37.29 | -1,109 | -207.47 | -179.86 | 229.65 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Long-Term Debt Repaid | - | -1.4 | -1.63 | - | -1.33 | - |
Net Debt Issued (Repaid) | -1.4 | -1.4 | -1.63 | - | -1.33 | - |
Issuance of Common Stock | - | - | - | - | - | 1,416 |
Common Dividends Paid | -72 | -72 | -138.24 | -96 | -72 | - |
Other Financing Activities | - | - | - | -1.17 | -4.06 | -11.02 |
Financing Cash Flow | -73.4 | -73.4 | -139.87 | -97.17 | -77.39 | 1,405 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -2.02 | -1.14 | 2.07 | 3.81 | 4.93 | -4.42 |
Net Cash Flow | -78.25 | -104.28 | -1,151 | -163.76 | -1.53 | 1,754 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -45.72 | -44.78 | -68.36 | -49.47 | 174.84 | 102.92 |
Free Cash Flow Growth | - | - | - | - | 69.89% | -4.96% |
Free Cash Flow Margin | -9.96% | -9.88% | -15.33% | -7.46% | 33.96% | 19.04% |
Free Cash Flow Per Share | -0.11 | -0.10 | -0.16 | -0.12 | 0.42 | 0.33 |
Levered Free Cash Flow | -48.78 | -57.02 | -94.01 | -118.8 | 102.2 | 64.84 |
Unlevered Free Cash Flow | -48.68 | -56.91 | -93.82 | -118.61 | 102.42 | 64.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 6.79 | 8.67 | 8.79 | 32.92 | 8.73 | 32.4 |
Change in Working Capital | -47.79 | -47.79 | -0.59 | -55.1 | 108.93 | -11.85 |